Abstract:To study the relationship between T helper (Th) 17 cell [CD4 +interleukin (IL)-17 +T lymphocytes]in peripheral blood and acute rejection in patients after liver transplantation.Methods A total of 76 patients receiving orthotopic liver transplantation (OLT)for benign end-stage liver diseases in Department of Hepatobiliary and Pancreas-Spleen Surgery,Affiliated Beijing Chaoyang Hospital of Capital Medical University from June 2008 to December 2012 were included in this study. According to whether the acute rejection occurred after operation,the patients were divided into rejection group (n=17)and non-rejection group (n=59). All the patients were followed up regularly by routine. The incidence of rejection and the treatment of patients were recorded. Patients in the rejection group received liver biopsy when suffered acute rejection to decide the severity. The percentage of CD4 +IL-17 +T lymphocytes to CD4 +T lymphocytes (CD4 +IL-17 +T%)in peripheral blood in all patients was measured at different time points:pre-OLT,at regular intervals (3-6 months)within 1 year after hospital discharge or before the treatment of acute rejection and after the remission (3-6 months). The CD4 +IL-17 +T% of every time point were compared between two groups.The correlations of CD4 +IL-17 +T% with the rejection activity index (RAI ), blood concentration of immunosuppressor were analyzed.Results The acute rejection occurred in 0.7-12.0 (median:2.5 ) months after OLT. The CD4 +IL-17 +T% in the rejection group increased significantly compared with that in the non-rejection group after OLT [(2.56 ±0.43)%vs. (1.79 ±0.44)%,P<0.001]. In the rejection group,the CD4 +IL-17 +T% increased significantly when acute rejection occurred compared with that when acute rejection had not occurred [(2.56 ±0.43)%vs. (1.50 ±0.25)%,P<0.001)]. The variation of CD4 +IL-17 +T%was not obvious at different time points in non-rejection group (P >0.05 ). The CD4 +IL-17 +T% was positively correlated with RAI when acute rejection occurred in the rejection group (r=0.72,P=0.001 ).The blood concentration of tacrolimus,cyclosporin in rejection and non-rejection group were not correlated with CD4 +IL-17 +T% (r=0.21,-0.13;both in P>0.05). Conclusions CD4 +IL-17 +T%in peripheral blood can be used as a monitoring index for deciding and assessing severity of acute rejection after OLT. The increase of CD4 +IL-17 +T% in peripheral blood indicates a severe acute rejection.

Study on the Inspection and Significance of Serum Soluble Interleukin-2 Receptor and Interleukin-6 Level in Bile after Liver Transplantation

Significance of Sil-2R and IL-6 in the Diagnosis of Acute Rejection and Bacterial Infection During Liver Transplantation

Diagnosis Value of the Expression of CD44 in Acute Rejection after Human Liver Transplantation

Determination of serum bile acid in patients after liver transplantation

Relationship of Chemokine IP-10 and Its Soluble CXCR3 in Bile with Acute Graft Rejection after Liver Transplantation

IMPACT OF PRE-TRANSPLANT SERUM LEVELS OF IP-10,MIG AND BLC ON ACUTE REJECTION EPISODE

Acute rejection episodic outcomes resulted from pre-transplant serum level of the soluble CD30 in kidney transplant recipients

Serum IL-8 levels correlate with acute rejection in recipient with human living-related small bowel transplantation

Clinical Implication of Monitoring Interleukin-18 Receptor on Peripheral Lymphocytes for Diagnosis and Treatment of Rejection after Renal Transplantation

Evaluation of perioperative serum cytokine level in acute rejection in human living-related small bowel transplantation

Variation and significance of T helper 17 cells in peripheral blood in patients after liver transplantation

Soluble interleukin‐2 receptor monitoring during bacterial and viral infections in liver transplant recipients: A comparative evaluation 1

Elevated serum IL-21 levels are associated with stable immune status in kidney transplant recipients and a mouse model of kidney transplantation

Differentiation Between Transient Intrahepatic Cholestasis and Acute Rejection after Liver Transplantation

Interleukin 6 and interleukin 17A serum levels and gene- polymorphisms in the development of early allograft rejection in living donor liver transplant recipients

Level Changes and Clinical Significance of Plasma IL-18,IP-10 in Patients with Chronic Hepatitis B During Antiviral Treatment

Serum levels of soluble interleukin‐2 receptor (sIL‐2R) fail to correlate with the occurrence and degree of rejection in heart transplant patients

Relationship Between Hepatic Pathological Changes and Serum Soluble Interleukin-2 Receptor Levels in Chronic Hepatitis B

THE CHANGE OFT-LYMPHOCYTE SUBSETS IN ACUTE REJECTION IN RECIPIENTS OF LIVER TRANSPLANTATION

Role of Chemokine and Its Receptor in Prediction of Early Acute Rejection after Liver Transplantation

Expression of Circulating CD4+ CD25+ Foxp3+ Regulatory T Cells in Liver Allograft Recipients with Acute Rejection